Prelude Therapeutics Incorporated - Common Stock — 四半期キャッシュフロー (NASDAQ:PRLD) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

総資産 175.51 M141.26 M114.92 M94.75 M141.31 M119.64 M 負債合計 44.06 M38.08 M39.08 M36.22 M72.68 M59.46 M 純資産合計 131.46 M103.18 M75.84 M58.53 M68.64 M60.18 M 負債および純資産合計 175.51 M141.26 M114.92 M94.75 M141.31 M119.64 M 有利子負債合計 —————— 純負債 ——————

ニュース

Wall Street Analysts Think Prelude Therapeutics (PRLD) Could Surge 33.59%: Read This Before Placing a Bet

Prelude Therapeuticsが最大2500万ドルの株式をJefferiesを通じて売却へ

Prelude Therapeutics files to offer up to $25 million in stock through Jefferies

Citizens、JAK2の可能性を評価しPrelude Therapeuticsの目標株価を引き上げ

Citizens raises Prelude Therapeutics price target on JAK2 potential

プレリュード・セラピューティクス株、シティズンズから「市場アウトパフォーム」評価を再確認

Prelude Therapeutics stock gets reiterated Market Outperform rating at Citizens

プレリュード・セラピューティクス株、がん治療薬のIND承認で急騰

Prelude Therapeutics stock surges after FDA clears IND for cancer drug

Tracking Baker Brothers Portfolio – Q3 2025 Update (NASDAQ:INCY)

Prelude Therapeutics stock rating reiterated at Market Outperform by Citizens

Beat the Market the Zacks Way: Goldman Sachs, Micron, Prelude in Focus